ELEMENT BIOSCIENCES
LIVE

Serial Number

90763884

Owner

Element Biosciences, Inc.

Attorney

SAMANTHA C MARKLEY

Filing Date

Jun 9, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ELEMENT BIOSCIENCES Trademark

Serial Number: 90763884

ELEMENT BIOSCIENCES is a trademark filed by Element Biosciences, Inc. on June 9, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Element Biosciences, Inc. (38 trademarks)

9880 Campus Point Drive, Suite 210
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

June 9, 2021

Registration Date

Not Registered

Published for Opposition

November 19, 2024

Goods & Services

Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for scientific research use, for diagnostic scientific use, and for clinical laboratory research use; clinical diagnostic reagents for laboratory use; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic laboratory purposes; none of the forgoing for use in the veterinary field

Providing reagent sample diagnostic testing services for others for scientific research purposes and scientific research related thereto; clinical diagnostic services for scientific research purposes, namely, preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids from human beings

Computer systems, namely, computer hardware, downloadable and recorded computer software and associated downloadable data files for collecting, storing, analyzing and reporting biological information, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable and recorded computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes

Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical medical diagnostic purposes; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers; all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for diagnostic medical use and for clinical medical use; none of the forgoing for use in the veterinary field

Clinical diagnostic instruments for medical use, namely, nucleic acid sequencers, imaging devices and analyzers, none of the forgoing for use in the veterinary field

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 2, 2026 EXRA
SOU EXTENSION 2 GRANTED
May 1, 2026 EX2G
SOU EXTENSION 2 FILED
May 1, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
May 1, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 4, 2025 EXRA
SOU EXTENSION 1 GRANTED
Nov 3, 2025 EX1G
SOU EXTENSION 1 FILED
Nov 3, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 3, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 6, 2025 NOAM
POST PUBLICATION AMENDMENT - ENTERED
Apr 15, 2025 CHPB
ASSIGNED TO PETITION STAFF
Apr 14, 2025 APET
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Mar 30, 2025 ETOP
TEAS POST PUBLICATION AMENDMENT RECEIVED
Mar 12, 2025 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 18, 2024 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 19, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2024 NONP
EXPARTE APPEAL TERMINATED
Oct 6, 2024 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 5, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 27, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 26, 2024 ERFR
EX PARTE APPEAL-INSTITUTED
Aug 26, 2024 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 26, 2024 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Aug 26, 2024 EXAF
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 20, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 20, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 29, 2024 GNFN
FINAL REFUSAL E-MAILED
Feb 29, 2024 GNFR
FINAL REFUSAL WRITTEN
Feb 29, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 25, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 26, 2023 GNRN
NON-FINAL ACTION E-MAILED
Oct 26, 2023 GNRT
NON-FINAL ACTION WRITTEN
Oct 26, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 29, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 29, 2023 CRFA
ASSIGNED TO LIE
Sep 29, 2023 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 10, 2023 ERSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 13, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 30, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 30, 2022 GNSL
SUSPENSION LETTER WRITTEN
Sep 30, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 8, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 8, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 8, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 9, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 9, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 9, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 28, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2021 NWOS
NEW APPLICATION ENTERED
Jun 12, 2021 NWAP